Our findings suggest that disease progression in CFAP300-associated PCD is age-dependent, which underscores the critical need for early genetic and functional diagnostics, as well as the utility of multimodal monitoring in older PCD patients to anticipate and manage advanced complications. The gene discussed is CFAP300; the disease is primary ciliary dyskinesia.